[1] Lee AY. Epidemiology and management of venous thromboembolism in patients with cancer [J]. Thromb Res,2003,110(4):167-172 . [2] Seemungal T, Sykes A, ICEAD Contributors. Recent advances in exacerbations of COPD[J]. Thorax,2008,63(10):850-852. [3] Greene CM,Miller SD,Carroll T,et al. Alpha-1 antitrypsin deficiency:a conformational disease associated with lung and liver manifestations[J]. J Inherit Metab Dis,2008,31(1):21-34. [4] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2007 年修订版)[J]. 中华结核和呼吸杂志,2007,30(1):8-17. [5] Van Eeden SF,Yeung A,Quinlam K,et al.Systemic response to ambient particulate matter:relevance to chronic obstructive pulmonary disease[J]. Proc Am Thorac Soc,2005,2(1):61-67. [6] Gould JM, Weiser JN. Expression of C-reactive protein in the human respiratory tract [J]. Infect Immun,2001,69(3):1747-1754. [7] Volanakis JE. Human C-reactive protein:expression,structure, and function[J]. Mol Immunol,2001,38(2-3): 189-197. [8] Okamura JM,Miyagi JM,Terada K,et al. Potential clinical applications of C-reactive protein[J]. J Clin Lab Anal, 1990,4(3):231-235. [9] Almirall J,Bolibar I,Toran P,et al.Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia [J]. Chest,2004,125(4):1335-1342. [10] 胡 玲,李伟铭.肺炎患者测定超敏C反应蛋白的临床价值[J]. 四川医学,2011,32 (2):205-207. [11] 王 庸.现代临床检验学[M].第2版.北京:人民军医出版社,2007: 26. [12] 刘贤兵,陈传辉,张 伟. 低气温条件下中重度慢性阻塞性肺疾病患者血清α1-抗胰蛋白酶含量变化及临床意义[J]. 实用临床医学,2010,11(6):9-11. [13] 付 群. 慢性阻塞性肺疾病患者血清α1-抗胰蛋白酶和白三烯变化的临床意义[J].山东医药,2008,48(13):38-39. |